Terms: = Colorectal cancer AND PER1, O15534, 5187, ENSG00000179094, RIGUI AND Treatment
5 results:
1. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
2. Factors associated with the initiation of chemotherapy within 90 days of death in metastatic colorectal cancer patients: a population-based study.
Batra A; McKinnon G; Billawala A; Sheka D; Kong S; Cheung WY
Support Care Cancer; 2021 Mar; 29(3):1535-1542. PubMed ID: 32725376
[TBL] [Abstract] [Full Text] [Related]
3. Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic colorectal cancer.
Han J; Xiao D; Tan C; Zeng X; Hu H; Zeng S; Jiang Q; She L; Yao L; Li L; Tang L; Ma J; Huang J; Shen L
Cancer Control; 2020; 27(1):1073274820902271. PubMed ID: 32107929
[TBL] [Abstract] [Full Text] [Related]
4. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
[TBL] [Abstract] [Full Text] [Related]
5. Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.
Lu H; Chu Q; Xie G; Han H; Chen Z; Xu B; Yue Z
Int J Clin Exp Pathol; 2015; 8(9):10985-94. PubMed ID: 26617816
[TBL] [Abstract] [Full Text] [Related]
